# Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock

> **NCT05283317** · PHASE1,PHASE2 · COMPLETED · sponsor: **TC Erciyes University** · enrollment: 30 (actual)

## Conditions studied

- Sepsis
- Septic Shock

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells

## Key facts

- **NCT ID:** NCT05283317
- **Lead sponsor:** TC Erciyes University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-11
- **Primary completion:** 2019-08-25
- **Final completion:** 2019-11-13
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05283317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05283317, "Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05283317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*